Compugen (CGEN) Payables (2009 - 2026)
Compugen recorded quarterly Payables of $2.5 million in Q1 2026, up 7.35% quarter-over-quarter from $2.4 million in Q4 2025.
Compugen's Payables history runs 11 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Payables changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (changed N/A YoY), while the FY2025 annual figure was $2.4 million, up 28.02% from the prior year.
- Payables came in at $2.5 million for Q1 2026 at Compugen, up from $2.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $9.2 million in Q4 2022 to a low of $1.8 million in Q4 2024.
- A 5-year average of $3.9 million and a median of $2.5 million in 2026 frame the typical range for Payables.
- Across the five-year window, Payables surged 99.26% in 2022 and plunged 61.97% in 2023, its largest moves.
- Compugen's Payables stood at $9.2 million in 2022, then slumped by 61.97% to $3.5 million in 2023, then sank by 47.52% to $1.8 million in 2024, then advanced by 28.02% to $2.4 million in 2025, then climbed by 7.35% to $2.5 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $2.5 million, $2.4 million, and $1.8 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Jun 30, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Dec 31, 2022 | 9.21 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Dec 31, 2021 | 4.62 Mn |
| Jun 30, 2021 | 1.81 Mn |
| Dec 31, 2020 | 7.80 Mn |
| Jun 30, 2020 | 1.11 Mn |
| Dec 31, 2019 | 1.09 Mn |
| Jun 30, 2019 | 1.15 Mn |
| Dec 31, 2018 | 2.95 Mn |
| Jun 30, 2018 | 1.76 Mn |
| Dec 31, 2017 | 3.45 Mn |
| Jun 30, 2017 | 2.12 Mn |
| Dec 31, 2016 | 1.27 Mn |
| Jun 30, 2016 | 1.31 Mn |
| Dec 31, 2015 | 2.00 Mn |
| Jun 30, 2015 | 1.21 Mn |
| Dec 31, 2014 | 1.49 Mn |
| Jun 30, 2014 | 1.33 Mn |
| Dec 31, 2013 | 693,000.00 |
| Jun 30, 2013 | 857,000.00 |
| Dec 31, 2012 | 443,000.00 |
| Sep 30, 2012 | 1.75 Mn |
| Jun 30, 2012 | 335,000.00 |
| Mar 31, 2012 | 2.10 Mn |
| Dec 31, 2011 | 248,000.00 |
| Sep 30, 2011 | 1.38 Mn |
| Jun 30, 2011 | 286,000.00 |
| Mar 31, 2011 | 1.60 Mn |
| Dec 31, 2010 | 1.93 Mn |
| Sep 30, 2010 | 247,000.00 |
| Jun 30, 2010 | 1.08 Mn |
| Mar 31, 2010 | 1.54 Mn |
| Dec 31, 2009 | 1.36 Mn |
| Sep 30, 2009 | 1.23 Mn |
| Jun 30, 2009 | 335,000.00 |
| Mar 31, 2009 | 1.29 Mn |